联邦监狱局抗菌药物管理:前瞻性审核反馈联合处方集变更减少氟喹诺酮不合理使用
该研究在联邦监狱局(FBOP)实施针对氟喹诺酮的前瞻性审核与反馈(PAF)及环丙沙星、左氧氟沙星处方集限制。实施后每千名在押成人氟喹诺酮医嘱减少46.4%(P < 0.0001),非处方集批准率平均62%。结论支持处方集变更联合PAF在非传统医疗场景的有效性。
要点
- 处方集限制联合PAF可使每千名在押成人氟喹诺酮医嘱减少46.4%。
- 多数PAF干预针对抗生素不必要或氟喹诺酮非推荐一线的情况。
- 环丙沙星和左氧氟沙星非处方集批准率平均为62%。
核心结论
- 处方集变更联合前瞻性审核与反馈在非传统医疗场景中可有效促进抗菌药物管理。
研究设计与样本
- 在联邦监狱局(FBOP)实施针对氟喹诺酮的PAF项目,并同时对环丙沙星和左氧氟沙星实施排除性处方集限制。
主要发现
- 实施后每千名在押成人(AICs)氟喹诺酮总医嘱减少46.4%(P < 0.0001)。
- 多数PAF干预涉及抗生素不必要或氟喹诺酮非推荐一线用药的情形。
- 同期环丙沙星和左氧氟沙星非处方集批准率平均为62%。
临床怎么用
- 在非传统医疗场景可联合处方集限制与PAF以减少氟喹诺酮不合理使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Antimicrobial stewardship programs have been widely implemented with positive results in the inpatient healthcare delivery model. However, data supporting these interventions is limited in other care settings. SUMMARY: Formulary restrictions and conducting prospective audit and feedback (PAF) are mainstays of antimicrobial stewardship. A PAF program targeted specifically at fluoroquinolone use was implemented in the Federal Bureau of Prisons (FBOP), in addition to exclusionary formulary restrictions on ciprofloxacin and levofloxacin. After implementation of these interventions, overall fluoroquinolone orders per 1,000 adults in custody (AICs) were reduced by 46.4% (P < 0.0001). The majority of PAF interventions addressed situations in which an antibiotic was unnecessary or a fluoroquinolone was not the recommended first-line agent. Over the same time period, nonformulary approval rates for ciprofloxacin and levofloxacin averaged 62%. CONCLUSION: The interventions from this program provide data supporting the effectiveness of formulary changes and PAF for antimicrobial stewardship in a nontraditional care setting.
引用
- Brorby A, Herring H, Williams E, et al. Antimicrobial stewardship in the Federal Bureau of Prisons: Combining prospective audit and feedback with formulary changes to reduce inappropriate fluoroquinolone use. Am J Health Syst Pharm. 2025. PMID: 39693371. doi:10.1093/ajhp/zxae394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。